Tokyo, June 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061870) titled 'Correlation between the predicted effect-site concentration and cerebrospinal fluid concentration of remimazolam' on June 12.
Study Type:
Observational
Primary Sponsor:
Institute - Niigata University
Condition:
Condition - Patients aged 18 years or older with ASA physical status 1-3 who are undergoing spinal surgery requiring a dural incision
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the correlation between the predicted effect-site concentration calculated using an existing pharmacokinetic model and the actual cerebrospinal fluid concentration o...